Cowen And Company »

Screaming Eagle Acq Class A shares owned by Cowen And Company

Quarter-by-quarter ownership of Screaming Eagle Acq Class A (SCRM) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Screaming Eagle Acq Class A

Tip: Access up to 7 years of quarterly data

All positions including Screaming Eagle Acq Class A held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Screaming Eagle Acq Class A by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $30M 2.9M 10.60
2023-09-30 $13M 1.2M 10.46
2023-06-30 $7.3M 711k 10.32

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Ptc Therapeutics I (PTCT)
Coinbase Global Com Cl A (COIN)
Avidity Biosciences Ord (RNA)
Sirius Xm Holdings (SIRI)
Tarsus Pharmaceuticals (TARS)
Churchill Capital Corp Vii Com Cl A (CVII)
Immunocore Hldgs Ads (IMCR)
Select Sector Spdr Tr Energy (XLE)
Rocket Pharmaceuticals (RCKT)
Mercer International (MERC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Sage Therapeutics (SAGE)
Alibaba Group Hldg Sponsored Ads (BABA)
Imperial Oil Com New (IMO)

View all positions for Cowen And Company

Top funds holding Screaming Eagle Acq Class A

Aristeia Capital
Vivaldi Asset Management
Millennium Management
Westchester Capital Management
Schechter Investment Advisors
Cowen And Company
CNH Partners
HGC Investment Management
Berkley W R
Kepos Capital
Kim
Picton Mahoney Asset Management
TD Asset Management
Two Sigma Investments
Brooklyn Capital Management

View all funds holding Screaming Eagle Acq Class A